Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Eveline K Hoebe"'
Autor:
Shannon C. Kenney, Jaap M. Middeldorp, Stacy R. Hagemeier, Eveline K Hoebe, Astrid E. Greijer, Coral K. Wille
Publikováno v:
Hoebe, E, Wille, C, Hagemeier, S, Kenney, S, Greijer, A & Middeldorp, J 2018, ' Epstein–barr virus gene BARF1 expression is regulated by the epithelial differentiation factor ∆np63α in undifferentiated nasopharyngeal carcinoma ', Cancers, vol. 10, no. 3, 76 . https://doi.org/10.3390/cancers10030076
Cancers; Volume 10; Issue 3; Pages: 76
Cancers
Cancers, 10(3):76. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 10, Iss 3, p 76 (2018)
Cancers; Volume 10; Issue 3; Pages: 76
Cancers
Cancers, 10(3):76. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 10, Iss 3, p 76 (2018)
Epstein–Barr Virus (EBV) BamHI-A rightward frame 1 (BARF1) protein is considered a viral oncogene in epithelial cells and has immune-modulating properties. During viral lytic replication BARF1 is expressed as an early gene, regulated by the immedia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9feda1c15d3574704376f1e69b2d43d
https://research.vumc.nl/en/publications/45d0992f-f66a-4e40-b147-d79a7f60956f
https://research.vumc.nl/en/publications/45d0992f-f66a-4e40-b147-d79a7f60956f
Autor:
Eveline K Hoebe, Dewi Kartikawati Paramita, Johanna M. Middeldorp, Astrid E. Greijer, Susanna Hilda Hutajulu, Servi J. C. Stevens, J. van Beek
Publikováno v:
Clinical and vaccine immunology, 18(2), 298-304. American Society for Microbiology
Clinical and Vaccine Immunology, 18(2), 298-304. American Society for Microbiology
Hoebe, E K, Hutajulu, S H, van Beek, J, Stevens, S J C, Paramita, D K, Greijer, A E & Middeldorp, J M 2011, ' Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients. ', Clinical and Vaccine Immunology, vol. 18, no. 2, pp. 298-304 . https://doi.org/10.1128/CVI.00193-10
Clinical and Vaccine Immunology, 18(2), 298-304. American Society for Microbiology
Hoebe, E K, Hutajulu, S H, van Beek, J, Stevens, S J C, Paramita, D K, Greijer, A E & Middeldorp, J M 2011, ' Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients. ', Clinical and Vaccine Immunology, vol. 18, no. 2, pp. 298-304 . https://doi.org/10.1128/CVI.00193-10
WHO type III nasopharyngeal carcinoma (NPC) is highly prevalent in Indonesia and 100% associated with Epstein-Barr virus (EBV). NPC tumor cells express viral proteins, including BARF1, which is secreted and is considered to have oncogenic and immune-
Publikováno v:
European journal of cancer (Oxford, England, 43(1), 175-183. Elsevier Limited
SN38 is the active metabolite of the anti-cancer agent irinotecan (CPT-11) and is a potent inhibitor of topoisomerase-I (topo-I), leading to DNA strand breaks and eventually cell death. The pyrimidine analog trifluorothymidine (TFT) is part of the an
Autor:
G.J. Peters, Stephen P. Ackland, Masakazu Fukushima, Eveline K Hoebe, Olaf H. Temmink, K. van der Born
Publikováno v:
British Journal of Cancer
British journal of cancer, 96(2), 231-240. Nature Publishing Group
British journal of cancer, 96(2), 231-240. Nature Publishing Group
Oxaliplatin (OHP) is an anticancer agent that acts by formation of Platinum-DNA (Pt-DNA) adducts resulting in DNA-strand breaks and is used for the treatment of colorectal cancer. The pyrimidine analog trifluorothymidine (TFT) forms together with a t
Autor:
Charlotte M. Huijts, Godefridus J. Peters, Auke D. Adema, Gareth J. Veal, Abolfazl Avan, Amir Avan, Eveline K. Hoebe, Katja Wosikowski, Rob Ruijtenbeek
Publikováno v:
Current Drug Targets, 15(14), 1312-1321. Bentham Science Publishers B.V.
Scopus-Elsevier
Avan, A, Adema, A D, Hoebe, E K, Huijts, C M, Avan, A, Veal, G J, Ruijtenbeek, R, Wosikowski, K & Peters, G J 2014, ' Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib ', Current Drug Targets, vol. 15, no. 14, pp. 1312-1321 . https://doi.org/10.2174/1389450115666141107110321
Current drug targets, 15(14), 1312-1321. Bentham Science Publishers B.V.
Scopus-Elsevier
Avan, A, Adema, A D, Hoebe, E K, Huijts, C M, Avan, A, Veal, G J, Ruijtenbeek, R, Wosikowski, K & Peters, G J 2014, ' Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib ', Current Drug Targets, vol. 15, no. 14, pp. 1312-1321 . https://doi.org/10.2174/1389450115666141107110321
Current drug targets, 15(14), 1312-1321. Bentham Science Publishers B.V.
The active metabolite (JM118) of the oral platinum analog satraplatin (JM216) was investigated for potential synergism with erlotinib, an epidermal growth factor receptor (EGFR) inhibitor. JM118 sensitivity of 7 cancer cell lines (ovarian: 2008, A278
Publikováno v:
Hoebe, E K, Le Large, T Y S, Greijer, A E & Middeldorp, J M 2013, ' BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator ', Reviews in Medical Virology, vol. 23, no. 6, pp. 367-383 . https://doi.org/10.1002/rmv.1758
Reviews in Medical Virology
Reviews in Medical Virology, 23(6), 367-383. John Wiley and Sons Ltd
Reviews in Medical Virology
Reviews in Medical Virology, 23(6), 367-383. John Wiley and Sons Ltd
Epstein–Barr virus (EBV) causes several benign and malignant disorders of lymphoid and epithelial origin. EBV-related tumors display distinct patterns of viral latent gene expression, of which the BamHI-A rightward frame 1 (BARF1) is selectively ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b17007a5663208d2452376ce7b1a9883
https://research.vumc.nl/en/publications/43580f64-f87d-4d8a-84c7-92485d2ae7d6
https://research.vumc.nl/en/publications/43580f64-f87d-4d8a-84c7-92485d2ae7d6
Autor:
Tessa Y S Le Large, Dinja Oosterhoff, Jaap M. Middeldorp, Astrid E. Greijer, Tanja D. de Gruijl, Eveline K Hoebe, Nicolas Tarbouriech
Publikováno v:
Viral immunology, 25(6), 461-470. Mary Ann Liebert Inc.
Hoebe, E K, Le Large, T Y S, Tarbouriech, N, Oosterhoff, D, de Gruijl, T D, Middeldorp, J M & Greijer, A E 2012, ' Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation ', Viral immunology, vol. 25, no. 6, pp. 461-470 . https://doi.org/10.1089/vim.2012.0034
Hoebe, E K, Le Large, T Y S, Tarbouriech, N, Oosterhoff, D, de Gruijl, T D, Middeldorp, J M & Greijer, A E 2012, ' Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation ', Viral immunology, vol. 25, no. 6, pp. 461-470 . https://doi.org/10.1089/vim.2012.0034
Epstein-Barr virus (EBV), like many other persistent herpes viruses, has acquired numerous mechanisms for subverting or evading immune surveillance. This study investigates the role of secreted EBV-encoded BARF1 protein (sBARF1) in creating an immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7a5e90740bbd23c1b75e3315f5c441
https://research.vumc.nl/en/publications/b2347c32-2c12-4fbd-b482-eb23c91b395b
https://research.vumc.nl/en/publications/b2347c32-2c12-4fbd-b482-eb23c91b395b
Autor:
Eveline K Hoebe, Erik S. Hopmans, Coral K. Wille, Jaap M. Middeldorp, Shannon C. Kenney, Astrid E. Greijer, Amanda R. Robinson
Publikováno v:
Journal of Virology, 86(20), 11322-11332. American Society for Microbiology
Journal of virology, 86(20), 11322-11332. American Society for Microbiology
Hoebe, E K, Wille, C, Hopmans, E S, Robinson, A R, Middeldorp, J M, Kenney, S C & Greijer, A E 2012, ' Epstein-Barr Virus Transcription Activator R Upregulates BARF1 Expression by Direct Binding to Its Promoter, Independent of Methylation ', Journal of Virology, vol. 86, no. 20, pp. 11322-11332 . https://doi.org/10.1128/JVI.01161-12
Journal of virology, 86(20), 11322-11332. American Society for Microbiology
Hoebe, E K, Wille, C, Hopmans, E S, Robinson, A R, Middeldorp, J M, Kenney, S C & Greijer, A E 2012, ' Epstein-Barr Virus Transcription Activator R Upregulates BARF1 Expression by Direct Binding to Its Promoter, Independent of Methylation ', Journal of Virology, vol. 86, no. 20, pp. 11322-11332 . https://doi.org/10.1128/JVI.01161-12
Epstein-Barr virus (EBV) BamHI-A rightward frame 1 (BARF1) is considered a major viral oncogene in epithelial cells and has immune-modulating properties. However, in B cells and lymphomas, BARF1 expression is restricted to the viral lytic replication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50cf228956775788c2a12f59532a5c31
https://research.vumc.nl/en/publications/47bde26e-b176-4686-b8fc-03e5140c1e16
https://research.vumc.nl/en/publications/47bde26e-b176-4686-b8fc-03e5140c1e16
Autor:
J. Sigmond, Godefridus J. Peters, Willem J.P Loves, Eveline K. Hoebe, Andries M. Bergman, Leticia G. Leon
Publikováno v:
Sigmond, J, Bergman, A M, Leon, L G, Loves, W J P, Hoebe, E K & Peters, G J 2010, ' Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase ', Anti-Cancer Drugs, vol. 21, no. 6, pp. 591-599 . https://doi.org/10.1097/CAD.0b013e32833a3543
Anti-cancer drugs, 21(6), 591-599. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 21(6), 591-599. Lippincott Williams and Wilkins
Anti-cancer drugs, 21(6), 591-599. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 21(6), 591-599. Lippincott Williams and Wilkins
Gemcitabine, a deoxycytidine analog, active against non-small cell lung cancer, is phosphorylated by deoxycytidine kinase (dCK) to active nucleotides. Earlier, we found increased sensitivity to gemcitabine in P-glycoprotein (SW-2R160) and multidrug r
Autor:
Eveline K Hoebe, Sandra A. W. M. Verkuijlen, Susanna Hilda Hutajulu, Bambang Hariwijanto, Servi J. C. Stevens, Sofia Mubarika Haryana, Astrid E. Greijer, Jajah Fachiroh, Jaap M. Middeldorp
Publikováno v:
Infectious Agents and Cancer
INFECTIOUS AGENTS AND CANCER, 5. BioMed Central
Hutajulu, S H, Hoebe, E K, Verkuijlen, S A W M, Fachiroh, J, Hariwijanto, B, Haryana, S M, Stevens, S J, Greijer, A E & Middeldorp, J M 2010, ' Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma ', Infectious Agents and Cancer, vol. 5, pp. 16 . https://doi.org/10.1186/1750-9378-5-16
Infectious Agents and Cancer, 5. BioMed Central
Infectious Agents and Cancer, Vol 5, Iss 1, p 16 (2010)
INFECTIOUS AGENTS AND CANCER, 5. BioMed Central
Hutajulu, S H, Hoebe, E K, Verkuijlen, S A W M, Fachiroh, J, Hariwijanto, B, Haryana, S M, Stevens, S J, Greijer, A E & Middeldorp, J M 2010, ' Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma ', Infectious Agents and Cancer, vol. 5, pp. 16 . https://doi.org/10.1186/1750-9378-5-16
Infectious Agents and Cancer, 5. BioMed Central
Infectious Agents and Cancer, Vol 5, Iss 1, p 16 (2010)
Background BamHI-A rightward frame-1 (BARF1) is a carcinoma-specific Epstein-Barr virus (EBV) encoded oncogene. Here we describe the BARF1 sequence diversity in nasopharyngeal carcinoma (NPC), other EBV-related diseases and Indonesian healthy EBV car